ML Agostini, G Schnell, J Iulio, A Kohli,
AE Shapiro… - Future …, 2024 - Taylor & Francis
Aim: Sotrovimab, an engineered human monoclonal antibody, targets a conserved region of
the SARS-CoV-2 spike protein. The phase III COMET-TAIL study evaluated noninferiority of …